Literature DB >> 28322461

Iodinated TG in Thyroid Follicular Lumen Regulates TTF-1 and PAX8 Expression via TSH/TSHR Signaling Pathway.

Huibin Huang1, Yaxiong Shi1, Bo Liang1, Huiyao Cai1, Qingyan Cai1.   

Abstract

Our previous study showed that highly iodinated thyroglobulin (TG) inhibited thyroid transcription factor-1 (TTF-1) and paired box gene 8 (PAX8) expression, but the potential mechanism remains unclear. In this study, we constructed a thyroid follicle model in vitro to mimic its natural physiological structure and explored how iodinated TG in the follicular lumen tuned TTF-1 and PAX8 expression. Our data showed that lowly iodinated TG enhanced PKA activity while upregulation of both TTF-1 and PAX8 expression; and that highly iodinated TG triggered PKC activity while suppression of TTF-1 and PAX8 expression. Further, PKA agonist alone could increase TTF-1 and PAX8 expression while PKC agonist decreased TTF-1 and PAX8 level. If blocking PLC-PKC pathway using PKC-specific inhibitor, highly iodinated TG significantly promoted the expressions of TTF-1 and PAX8, and similarly PKA-specific blocker moderately inhibited TTF-1 and PAX8 expression. And opposite tendencies of TTF1 and PAX8 aberrant expression were observed in the condition of low iodinated TG when blocking PLC-PKC and cAMP-PKA signaling pathways. Our results indicated that iodinated TG manipulated TTF-1 and PAX8 expression through PLC-PKC and cAMP-PKA pathways, and highly iodinated TG played inhibitory role via PLC-PKC pathway from the TTF1 and PAX8 perspective while low level of iodinated TG was an activator through cAMP-PKA pathway. Our findings proved that iodinated TG in thyroid follicular lumen regulated TTF-1 and PAX8 expression through thyroid stimulating hormone/thyroid stimulating hormone receptor (TSH/TSHR) mediated cAMP-PKA and PLC-PKC signaling pathways. J. Cell. Biochem. 118: 3444-3451, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  IODINATED TG; PAX8; TSH; TSHR; TTF-1

Mesh:

Substances:

Year:  2017        PMID: 28322461     DOI: 10.1002/jcb.26001

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  5 in total

1.  Two distinct E3 ligases, SCFFBXL19 and HECW1, degrade thyroid transcription factor 1 in normal thyroid epithelial and follicular thyroid carcinoma cells, respectively.

Authors:  Jia Liu; Su Dong; Heather Wang; Lian Li; Qinmao Ye; Yanhui Li; Jiaxing Miao; Sissy Jhiang; Jing Zhao; Yutong Zhao
Journal:  FASEB J       Date:  2019-06-25       Impact factor: 5.191

2.  The E3 ubiquitin ligase HECW1 targets thyroid transcription factor 1 (TTF1/NKX2.1) for its degradation in the ubiquitin-proteasome system.

Authors:  Jia Liu; Su Dong; Lian Li; Heather Wang; Jing Zhao; Yutong Zhao
Journal:  Cell Signal       Date:  2019-03-05       Impact factor: 4.315

3.  Genome-Wide Association Analysis and Genomic Prediction of Thyroglobulin Plasma Levels.

Authors:  Nikolina Pleić; Mirjana Babić Leko; Ivana Gunjača; Thibaud Boutin; Vesela Torlak; Antonela Matana; Ante Punda; Ozren Polašek; Caroline Hayward; Tatijana Zemunik
Journal:  Int J Mol Sci       Date:  2022-02-16       Impact factor: 5.923

Review 4.  Intrathyroidal feedforward and feedback network regulating thyroid hormone synthesis and secretion.

Authors:  Li Jing; Qiang Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-15       Impact factor: 6.055

5.  Molecular evidence reveals thyrotropin intervention enhances the risk of developing radioiodine-refractory differentiated thyroid carcinoma.

Authors:  Hilda Samimi; Vahid Haghpanah
Journal:  Cancer Cell Int       Date:  2022-02-03       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.